Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
HTS_TST |
By Key Population: FSW, Negative |
2018 |
10,077 |
HTS_TST |
By Key Population: MSM, Negative |
2018 |
2,750 |
HTS_TST |
By Key Population: TG, Negative |
2018 |
30 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2018 |
13,925 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative |
2018 |
516 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative |
2018 |
813 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative |
2018 |
1,403 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative |
2018 |
48 |
HTS_TST |
Service Delivery Point (Community) Other: 15-19, Female, Negative |
2018 |
1,854 |
HTS_TST |
Service Delivery Point (Community) Other: 20-24, Female, Negative |
2018 |
3,025 |
HTS_TST |
Service Delivery Point (Community) Other: 25-49, Female, Negative |
2018 |
4,992 |
HTS_TST |
Service Delivery Point (Community) Other: 50+, Female, Negative |
2018 |
206 |
HTS_TST |
Sum of Test Result disaggregates |
2018 |
1,069 |
HTS_TST_POS |
By Key Population: FSW, Positive |
2018 |
982 |
HTS_TST_POS |
By Key Population: MSM, Positive |
2018 |
85 |
HTS_TST_POS |
By Key Population: TG, Positive |
2018 |
1 |
HTS_TST_POS |
By Test Result: Positive |
2018 |
1,069 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive |
2018 |
4 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive |
2018 |
23 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive |
2018 |
59 |
HTS_TST_POS |
Service Delivery Point (Community) Other: 15-19, Female, Positive |
2018 |
39 |
HTS_TST_POS |
Service Delivery Point (Community) Other: 20-24, Female, Positive |
2018 |
399 |
HTS_TST_POS |
Service Delivery Point (Community) Other: 25-49, Female, Positive |
2018 |
541 |
HTS_TST_POS |
Service Delivery Point (Community) Other: 50+, Female, Positive |
2018 |
3 |
KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
13,823 |
KP_PREV |
By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
3,519 |
KP_PREV |
By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2018 |
63 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2018 |
17,405 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2018 |
571 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2018 |
529 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2018 |
26 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2018 |
56 |
TX_NEW |
FSW |
2018 |
571 |
TX_NEW |
FSW |
2018 |
529 |
TX_NEW |
MSM |
2018 |
26 |
TX_NEW |
MSM |
2018 |
56 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2018 |
597 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2018 |
585 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2018 |
597 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2018 |
585 |
TX_PVLS |
Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months |
2018 |
1,178 |
TX_PVLS |
Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months |
2018 |
946 |
TX_PVLS |
Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted |
2018 |
880 |
TX_PVLS |
Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted |
2018 |
66 |
TX_PVLS |
Numerator: Indication: Targeted |
2018 |
946 |
TX_PVLS_den |
Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted |
2018 |
1,096 |
TX_PVLS_den |
Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted |
2018 |
82 |
TX_PVLS_den |
Denominator: Indication: Targeted |
2018 |
1,174 |